Crespo Blas Coll - 15 Mar 2025 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Chief Medical Officer
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer symbol
GPCR
Transactions as of
15 Mar 2025
Net transactions value
$0
Form type
4
Filing time
18 Mar 2025, 20:45:17 UTC
Previous filing
03 Jul 2025
Next filing
22 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Award $0 +116,988 +114% $0.000000 219,588 15 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Employee Stock Option (right to buy) Award $0 +284,241 $0.000000 284,241 15 Mar 2025 Ordinary Shares 284,241 $7.02 Direct F1, F3, F4
transaction GPCR American Depositary Shares Award $0 +363 +99% $0.000000 728 20 Nov 2024 Ordinary Shares 1,089 Direct F1, F5, F6
holding GPCR American Depositary Shares 1,000 15 Mar 2025 Ordinary Shares 3,000 By spouse F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2 Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
F3 The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F4 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
F5 Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
F6 Voluntary reporting of the acquisition of 363 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.